CBD Forum by Chow420

Endless Summer SALE · UP TO 65% OFF Summer SALE · 65% OFF Ends in Bundle up & save · buy more, save more · up to 65% off Shop Bundles →
Go back
Refer for $20
$20
Refer
Get $20 in Chowcash when you refer friends, stores, and brands to Chow420. Your friends also get $20 towards their first purchase when they accept your invitation.
Login to Refer

Hemp News, Laws & Product Updates

A curated news hub focused on hemp regulation and policy changes, cannabinoids (CBD/Delta-8/Delta-9/hemp-derived THC), lab testing and COAs, product safety, brands, and industry trends.

  • Federal & State Hemp Laws
  • THC Policy
  • CBD / Delta-8
  • Compliance
  • Lab Testing (COA)
  • Product Safety
  • Industry & Brands
Back to Chow420
https://hightimes.com/

High Chris’ Zätix Is Pioneering Luxury Cannabis in California and Beyond

From the prospectors looking for gold in its hills to the tech campuses in its valleys, California has always been a fertile place for pioneers and innovators. It’s been a pioneering state for cannabis, too. Prop 215 made California the first state to legalize medicinal use. And even though it passed on the opportunity to become the first state to legalize recreational use, other states still look up to it for a regulatory framework. The fans of the plant look to its growers and cultivators for high-quality plants and boundary-pushing strains and products. Lately, they’ve been seeing a new trend emerge from one of the most mature cannabis markets in the country. It’s called luxury cannabis, and it promises to deliver a new type of experience for the discerning consumer. “It starts with taste. Taste is the most important part of cannabis, and it’s the hardest thing to achieve,” explains High Chris, the founder of Zätix, a pioneer in luxury cannabis. “Even if you grow an amazing-looking flower, and it looks the most beautiful, sparkly, crystally purple, today, it doesn’t mean anything unless it tastes good.” With over 20 years in the industry, Chris is one of the true veteran entrepreneurs operating in California’s cannabis market. With Zätix, his latest venture, he set on a mission to find the cannabis strains that would appeal to true connoisseurs who enjoy the finer things in life and believe that quality and taste trump insane levels of THC. “It’s almost like food. It’s easy to find mediocre food anywhere,” explains Chris. “But when you go to some high-end, fine dining restaurant where the chef makes something incredible that you’ve never had and you taste and say wow, this is amazing, I’ve never had anything like that — that’s what I’m getting at. That’s luxury cannabis.” Launching a luxury cannabis brand isn’t as simple as creating a regular one. For one, it wasn’t even financially feasible until California repelled its cultivation tax, which burdened significantly smaller, niche producers. Then, it was a task to find a cultivator that could produce the strains of cannabis that meet the highest standards. And even though they don’t necessarily have to create enormous quantities of it — luxury and exclusivity go hand in hand —a producer of a luxury cannabis flower needs to have tremendous consistency in their products. As an industry pioneer who also does consulting work, it wasn’t a problem for Chris to have a hands-on approach and make decisions that would put the quality of the product first, even ahead of cost-effectiveness. For example, he advised his cultivator against switching to LED lights from high-pressure sodium, even though LEDs were a more economical option because the switch would have changed the qualities that make their products consistently good. He contrasts his artisanal approach with corporations who see cannabis as an industry where they can make a quick buck. “Corporations tend not to understand this, and they approach it from a traditional corporate mindset of how we lower our costs and increase profits. That’s usually their main objective,” explains Chris. “And we’ve seen it in all sorts of industries, but in cannabis, it doesn’t work like that.” Zätix’s stance against cost-cutting measures extends to the second-biggest cost besides the product — packaging. For many brands, it’s a prime target to reduce some costs. For Zätix, it’s another opportunity to show what they’re about — quality, luxury, and going all-in to get the best possible experience. Presentation is a massive part of it, and it’s not something the brand would want to give up on. For Chris, being a part of the larger cannabis community is critical for his brand. “We try to go above and beyond and engage with the people supporting us as a brand and be part of the community because we come from the community,” he says. Zätix organizes its events, sponsors others’ events, and uses every opportunity to interact with the community and offer giveaways, samples, and an overall pleasant experience. Luxury cannabis is still cannabis. Its roots run deep, and people recognize it. “That’s the big thing. It’s the easiest thing for us to do and the hardest thing for the corporate people to do. They don’t come from this, and they are considered culture vultures,” Chris explains. Even though Chris’ plans for Zätix include growing the brand, he’s well aware that a luxury cannabis brand cannot be mass-produced while still keeping the same appeal. He’s okay with that — he knows he’s onto something special and is putting all of his expertise in maintaining its uniqueness. “I used to manage some artists when I was younger when I had my recording studio,” he says. “I had a unique background in the music industry and understood marketing and the full background in cannabis. So I combined the three, and that’s where we’re right now — I treat the brand as a musician.”

https://hightimes.com/

Hemp Cannabinoids Could Be Source of New Pesticides

Recent research into the potential uses of hemp shows that cannabinoids produced by the plant could one day be the source of new natural pesticides, according to researchers at Cornell University in New York. The study by scientists at the School of Integrative Plant Science at Cornell AgriTech’s College of Agriculture and Life Sciences (CALS) found that a higher concentration of cannabinoids in the leaves of hemp plants showed less damage from chewing insects compared with leaves less rich in cannabinoids.  The researchers hope that further study could build on these findings to eventually produce new natural insecticides, most likely for use on non-edible plants only. The potential for using the new pesticides on food crops seems unlikely at this point because of the pharmacological effects of cannabinoids including CBDA, THCA and GBGA, which can be converted to CBD, THC and CBG, respectively, with the addition of heat in a process known as decarboxylation.  Larry Smart, a plant breeder and professor at CALS, says that researchers have studied the intoxicating and medicinal effects of cannabinoids, which are produced almost exclusively by cannabis plants, since the compounds were first identified decades ago. But little research has been conducted to determine exactly why cannabis plants first developed the more than 100 distinct substances. “It has been speculated that they are defensive compounds, because they primarily accumulate in female flowers to protect seeds, which is a fairly common concept in plants,” said Smart, the senior author of the study, according to a report from Hemp Today. “But no one has put together a comprehensive set of experimental results to show a direct relationship between the accumulation of these cannabinoids and their harmful effects on insects,” Smart continued.  The research was conducted as part of Cornell’s hemp breeding program, which was launched by the Ivy League university in upstate New York in 2017. The program began its work by evaluating different commercially available hemp cultivars so recommendations could be made to farmers about which varieties are best suited to the local soil and climate.  The researchers noticed that varieties of hemp sourced from a breeding program in Ukraine that did not produce cannabinoids were all highly susceptible to damage from Japanese beetles. Other hemp varietals that produce cannabinoids were not similarly prone to damage from the insects. “In the absence of cannabinoids, we saw heavy insect damage, and in the presence of cannabinoids, we saw much less damage,” said Smart. The researchers then isolated CBDA and CBGA for use in controlled insect feeding studies. THCA was not studied as part of the research because strict federal limits on THC in hemp crops prevent Cornell researchers from working with the compound. The cannabinoid extracts were added to an artificial insect diet in varying concentrations. The researchers determined that insect larvae grew less and had lower rates of survival as the concentration of cannabinoids was increased. “The study gives us insight into how cannabinoids function in natural systems, and can help us develop new THC-compliant hemp cultivars that maintain these natural built-in defenses against herbivores,” said George Stack, a postdoctoral researcher in Smart’s lab and one of the authors of the new study. The researchers plan further investigation to determine if sap-sucking insects such as aphids are also adversely affected by cannabinoids. However, Stack noted that the research is hindered by the continued illegality of marijuana at the federal level. “The potential use of cannabinoids as a pesticide is an exciting area for future research, but there will certainly be regulatory barriers due to pharmacological activity of the compounds, and more studies are needed to understand what pests cannabinoids will be effective against,” Stack said. The study, “Cannabinoids Function in Defense Against Chewing Herbivores in Cannabis Sativa L.,” was published in October by the peer-reviewed journal Horticulture Research.

https://hightimes.com/

Scientists Chart How Ketamine Impacts Dopamine in Mice

A study, published this month in the journal Cell Reports, was based on the repeated use of ketamine in male mice.  “Ketamine is a multifunctional drug with clinical applications as an anesthetic, pain management medication, and a fast-acting antidepressant,” the researchers wrote in the summary of the study. “However, it is also recreationally abused for its dissociative effects.”  They noted that recent studies on rodents “are revealing the neuronal mechanisms mediating its actions, but the impact of prolonged exposure to ketamine on brain-wide networks remains less understood.”  As such, in their study, the researchers developed “a sub-cellular resolution whole-brain phenotyping approach and utilize it in male mice to show that repeated ketamine administration leads to a dose-dependent decrease in dopamine neurons in midbrain regions linked to behavioral states, alongside an increase in the hypothalamus.” “Additionally, diverse changes are observed in long-range innervations of the prefrontal cortex, striatum, and sensory areas,” they continued. “Furthermore, the data support a role for post-transcriptional regulation in enabling ketamine-induced neural plasticity. Through an unbiased, high-resolution whole-brain analysis, this study provides important insights into how chronic ketamine exposure reshapes brain-wide networks.” Ultimately, the experiment enabled the researchers to develop a “high-resolution whole-brain phenotyping of ketamine-treated animals.” “We established a complete pipeline for whole-brain labeling, high-resolution imaging, and comparative phenotyping of the entire dopaminergic modulatory system, and we utilized it to study the dose-dependent effects of daily (R,S)-ketamine exposure (30 and 100 mg/kg; 1, 5, and 10 days) and saline control intraperitoneal (i.p.) injections,” they explained. The results “revealed no significant cell death in the brain,” they said. “We used an unbiased, high-resolution whole-brain mapping approach to systematically investigate the adaptability of the DA system to repeated ketamine exposure,” the researchers explained. “We found that chronic ketamine exposure leads to a dosage-dependent decrease in DA neurons counts within midbrain regions related to behavior state and increase within hypothalamic domains, along with altered long-range innervation of the association and sensory areas by TH+ neuronal projections. Such structural plasticity of brain-wide modulatory system may facilitate significant reconfiguration of the neuronal networks to eventually result in long-lasting cognitive behavioral changes.”  As the outlet PsyPost explained, the study’s “findings provide evidence of significant structural plasticity in the brain’s dopaminergic system in response to chronic ketamine exposure.”  “In other words, the study shows that repeated use of ketamine can lead to major changes in the areas of the brain that deal with dopamine, a neurotransmitter that plays a pivotal role in mood, motivation, and reward systems,” PsyPost reported. The researchers behind the study said that it “sheds light on the brain-wide effects of chronic ketamine exposure on the dopamine system and provides insight into the structural plasticity that underlies these effects.”  “The finding that ketamine exposure leads to divergent alterations in specific brain regions, rather than a uniform activating impact, is particularly intriguing and could have significant implications for the development of treatments for depression, schizophrenia, and psychosis,” they said. “Moreover, such non-monolithic brain-wide impact further underscores the need for unbiased investigations of on/off-target effects of ketamine treatment at a range of doses, as well as the urgency to develop targeted pharmacological intervention approaches (e.g., focused ultra sound-based approaches 43,44) for treatment of complex brain disorders.” But despite those eye-opening revelations, the authors said that the study “also has a few limitations.”  “Firstly, the study did not examine the progressive changes in TH expression levels over varying durations of ketamine exposure. Instead, a binary approach of presence or absence was employed. In future research, the development of strategies for whole-brain expression signal normalization will be essential to enable a more comprehensive analysis of the gradual effects of prolonged ketamine exposure on the DA system,” the researchers explained. “Secondly, it’s crucial to note that TH is not exclusive to dopaminergic neurons but is also present in other catecholaminergic neurons, such as norepinephrine and epinephrine. While it is generally accepted that these neurons are primarily localized in specific regions of the hindbrain, some of the neuronal projections labeled as TH+ in this study may potentially originate from these other catecholaminergic neurons. Future studies will be necessary to precisely determine the neurotransmitter identity (whether DA or noradrenergic) of the affected neuronal projections.” They continued, “Thirdly, this study does not provide specific insights into the physiological mechanisms that may be mediating the impact of chronic ketamine exposure on the DA system. Fourthly, to ensure the practical feasibility of performing sub-cellular resolution comparative phenotyping, this initial whole-brain study utilized male mice to minimize potential sources of variability. Future research, building upon these initial important findings and tools, will be needed to explore any potential sex-specific impact of ketamine exposure.45 Lastly, it should be noted that the current study employed a mixture of (R,S) enantiomers of ketamine. Future follow-up studies will be necessary to understand the relative impacts of the two ketamine enantiomers.”

https://hightimes.com/

Medical Cannabis Clinical Trial in U.K. Underway

Although the United Kingdom (U.K.) legalized medical cannabis in 2018, it has not approved any clinical studies and is not widely available as a prescription through the country’s National Health Services (NHS). A recent report from Sky News provided an update on the NHS, stating that no studies have been funded to help explore the efficacy of medical cannabis yet. However, U.K.-based Celadon Pharmaceuticals recently began a clinical trial featuring 5,000 patients who suffer from chronic pain. Earlier this year in March, Celadon Pharmaceuticals became the first company in the U.K. to be licensed by the British government, called the Home Office, to sell its products to private clinics that are legally allowed to prescribe cannabis. At first Celadon Pharmaceuticals conducted a preliminary study, examining 500 patients and found that cannabis did help reduce patients’ reliance on opioids, and also helped improve sleep. This past summer, both the Medicines and Healthcare products Regulatory Agency (MHRA) and the NHS Research Ethics Committee approved of the larger Celadon clinical trial. “As an approved Trial, it is believed to be the only one of its kind in the U.K., and is designed to create a data set that will support doctors’ prescriptions of cannabis-based medicines, and in time enable potential reimbursement by the NHS and insurance companies,” the company wrote in a press release this summer. “It also enables General Practitioners to prescribe the medicine to patients in addition to specialist doctors, and organisations such as charities can advertise recruitment for the Trial. The Company believes this to be a major advance in enabling much wider access for patients, ultimately leading to the opening up of the UK market for cannabis-based medicines.” Celadon’s co-founder, James Short, more recently told Sky News that first and foremost, his business is a pharmaceutical company, not a cannabis company. “We’ve got to try and get away from the stigma. When I first got involved in the business I was nervous to even talk about it with friends,” Short said. “But our job is not to get people high. It’s to give them a better quality of life.” Numerous patients, especially parents of young patients, have spoken out in favor of medical cannabis, and called the government to take action so that it could be more accessible and affordable for families. Hannah Deacon and her son Alfie Dingley, Emma Appleby and her daughter Teagan, Emma Matthews and her son Louis, Matt Hughes and his son Charlie, and Karen Gray and her son Murray from Scotland are just a few recognizable names of U.K.-based parents fighting for their kids’ rights to cannabis and an improved quality of life. Families outside of the U.K. such as Irish mother Vera Twomey had called upon their own governments for improved treatment opportunities for her daughter, Ava, who suffered from Dravet syndrome. Sadly, Ava passed away earlier this year in May at age 13. While there are many firsthand accounts of medical cannabis helping patients, U.K. doctors still remain hesitant. “In the aftermath of what happened with opioids the medical community is understandably a little bit skeptical about introducing a new drug without really robust evidence,” said NHS consultant and British Pain Society spokesperson, Dr. Alan Fayaz. “The opioid epidemic has perhaps done cannabis a bit of a disservice because it’s tainted ground.” Furthermore, Fayaz said that the 2018 law change coming before clinical evidence was clear has been harmful to the cause. “It creates this bizarre two-tiered system which actually doesn’t advantage the patients on the NHS and it doesn’t really advantage the patients in the private sector either,” Fayaz explained. “I think what we need is the research to be able to identify the role cannabis will play.” Currently only patients who manage a private prescription are able to gain access, which is incredibly expensive. Sky News spoke with Chad Martin, who pays £300 per month ($378 USD) to obtain medical cannabis to treat his arthritis. “I am fortunate to be able to afford the drug. Others can’t,” Martin explained. Initially his doctor prescribed opioids to treat his condition. His cannabis medicine of choice is a cannabis inhaler, which helps treat pain and inflammation flare-ups. “When the weather changes, arthritis can affect you regardless, but cannabis has worked way better than anything else I’ve taken in the past,” Martin said. The Home Office launched its cannabis review in June 2018. At the same time, the Home Secretary also announced that Alfie Dingley and Billy Caldwell would be granted a license to legally obtain cannabis to treat their conditions.In 2019, the National Institute for Health and Care Excellence (NICE) decided that there wasn’t enough evidence that medical cannabis can help patients who suffer from epilepsy. Later in March 2021, NICE updated its 2019 stance on medical cannabis, clarifying that “There is no recommendation against the use of cannabis-based medicinal products.” Two years later in March 2023, NICE approved Epidyolex, a CBD-based medicine, for those who suffer from tuberous sclerosis complex.

https://hightimes.com/

Drug Makers Struggle to Replace Stimulants with Non-Addictive Alternatives

Unfortunately, the same drugs with high potential for abuse are also the ones that work best for certain individuals with neurobehavioral conditions. According to GlobalData, penetrating the stimulant-dominated pharmaceutical market remains challenging without comparable efficacy from non-stimulants.  The attention deficit hyperactivity disorder (ADHD) market is a lucrative business: Stimulants, amphetamines, and methylphenidates continue to dominate the ADHD drug market across the seven major markets, Express Pharma reports. (The seven major markets are in France, Germany, Italy, Spain, the UK, the US, and Japan.) Non-addictive drugs demonstrate a “crippling lower” efficacy in treating ADHD. Drug makers are in a race to develop safer alternatives. Three out of the four late-stage pipeline drug candidates in Phase III development within those markets have non-stimulant properties: Axsome Therapeutics Inc’s solriamfetol, Otsuka Pharmaceutical Co Ltd’s centanafadine and Neurocentria Inc’s L-Threonate Magnesium Salt.  The lower abuse potential of solriamfetol and centanafadine is a major selling point created by developers, but without displaying efficacy comparable to stimulants, they will struggle to penetrate the market—even if they are approved. The use of stimulants for ADHD treatment is increasing. The key opinion leaders (KOLs) in the treatment of ADHD say that patients and parents have been hesitant to use stimulants for the treatment of ADHD in children and adolescents, but this is changing with time, and the use of stimulants for ADHD treatment is increasing. “Marketing emphasis on abuse potential is common in non-stimulates both marketed and pipeline; this is despite KOLs viewing the abuse potential of ADHD stimulants as overstated,” said Lorraine Palmer, Pharma Analyst at GlobalData. “The KOLs interviewed by GlobalData were not concerned about whether a treatment is a stimulant or a non-stimulant, rather they are focused on the pharmaceuticals efficacy and side-effect profile.” Four non-stimulants are commonly marketed: guanfacine, clonidine, atomoxetine and viloxazine. Sleep disturbances and a decreased appetite have been reported from both clonidine and atomoxetine.  “All four display cripplingly lower efficacy in the treatment of ADHD than stimulants,” Express Pharma reports. “Rather than an emphasis on abuse potential, a better alternative strategy to penetrate the saturated ADHD market would be to target key unmet needs in ADHD treatment such as improving compliance or providing coverage into the evening without affecting sleep.” Part of this challenge likely includes the impact of addiction itself.  Regarding the popular ADHD drug Adderall, adults and children 6 years of age and older are eligible to take Adderall, beginning at 5 milligrams, while children 3 to 5 years of age are able to start at 2.5 mg per day. Only children under the age of 3 are prohibited from being prescribed the drug in all cases. Adderall’s active ingredients are dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate. Columbia University psychiatry professor Carl Hart famously wrote for Vice in 2016 that meth is “almost identical to Adderall” in terms of chemistry and its effects on the brain. A 2016 study published in the Journal of Clinical Psychiatry indicates that an increasing number of young adults have been checking into emergency rooms over the past few years due to accidental overdoses on Adderall and similar drugs. High Times reported last September that leading drug makers and pharmaceutical companies are having little luck addressing nationwide shortages of stimulant-based ADHD medications like Adderall, Vyvanse, and Ritalin. The Adderall shortage began in Fall of 2022, marked by an FDA notice acknowledging the shortages with an estimate that things would be resolved in a month or two. That is not the case, however, as issued a joint notice on August 1 acknowledging that the shortage had been “understandably frustrating” for patients and providers. “The current shortage of stimulant medications is the result of many factors. It began last fall due to a manufacturing delay experienced by one drug maker,” the joint notice said. “While this delay has since resolved, we are continuing to experience its effects in combination with record-high prescription rates of stimulant medications. Data show that, from 2012 to 2021, overall dispensing of stimulants (including amphetamine products and other stimulants) increased by 45.5 percent in the United States.”  Teva Pharmaceuticals, Adderall’s biggest manufacturer, reported shortfalls. Teva CEO Richard Francis told Bloomberg that the company is operating at “full capacity” at the moment and blamed their decreased output in previous years to COVID-induced work shortages which they have only just barely recovered from. Should they wish to increase the amount of Adderall they produce, they would have to buy or build more factories as their current infrastructure cannot handle bigger output. The company has declined to comment on whether or not they plan to invest in such infrastructure. This adds to the multiple reasons less addictive non-stimulant drugs are needed to treat ADHD.

https://hightimes.com/

Tennessee Authorities Find Weed Cultivation Site Inside Church

Law enforcement officials in Tennessee have shut down a cannabis cultivation site that was operating in a converted church, seizing about 2,000 weed plants in the process. The raid on the church, which was conducted last week by the Stewart County Sheriff’s Office (SCSO), was the result of a weeks-long investigation, according to law enforcement officials. Although the plant count was not especially high for commercial marijuana growing operations, Sheriff Frankie Gray noted that the bust shut down Stewart County’s largest discovered weed farm ever. “The sheriff’s office shut down the largest marijuana grow in county history,” Gray said in a statement to local media. In a social media post on Friday, the sheriff’s office noted that deputies had been conducting an investigation of the church for three weeks after local residents reported a strong odor emanating from the property. The investigators conducted traffic stops to question people they had seen coming from and going to the church and were told that hemp was being grown at the site, which is legal in Tennessee with a license from the state. Sheriff’s deputies also investigated the electricity and water usage at the property, which was originally built as a Methodist church in 1960 and later sold. Investigators learned that the grow operation had a water bill that was characterized by local media as “high” and was using about $3,000 per month in electricity. Last week, the SCSO obtained a search warrant for the church on Highway 46 in the community of Indian Mound. Sheriff’s deputies and law enforcement officers from the 23rd Judicial Drug Task Force then raided the site on Thursday and discovered about 2,000 cannabis plants including live plants and others that had already been harvested and dried. The Tennessee Bureau of Investigation also assisted in serving the search warrant. The sheriff’s office said the marijuana cultivation operation included elaborate lighting and watering systems operated by automatic timers. The agency also reported that the search of the site was slowed as deputies investigated “the possibility of booby traps laid out for law enforcement.” The SCSO also reported that investigators found “a large amount of possibly toxic chemicals” at the site. Law enforcement officers took one person into custody when the search warrant was served, although officials did not specify what charges the individual was being held on. Others are wanted for questioning, the sheriff’s office said. The converted church, which is located in northern central Tennessee about 70 miles northwest of Nashville, is listed for sale on Zillow, according to media reports. The property is listed as having four bedrooms and three bathrooms. The listing also notes that the site, which formerly had two buildings, was converted into one building with the addition of a breezeway. The person posting the listing said they were “looking for a quick sale” of the property. Tennessee is one of only about a dozen U.S. states that have not adopted a comprehensive plan to legalize medical marijuana, although a limited measure to legalize low-THC CBD oil was passed in 2015. Possession of even small amounts of cannabis is still a misdemeanor criminal offense. Those who commented on the social media post from the sheriff’s office in conservative Stewart County were mostly in favor of the law enforcement action to shut down the cannabis cultivation site discovered at the church last week. “Our Law Enforcement Agency is always on top of things. Great job!” one person commented. “Thank you for shutting this operation down,” said another. “Your hard work is appreciated. Stay safe.” “Thankful for our sheriff’s department and all involved,” added a third Facebook user.

https://hightimes.com/

Recreational Pot Surges in Rhode Island’s First Year of Legal Sales

Local news outlet WPRI reported last week that the state’s Office of Cannabis Regulation says that recreational marijuana sales “have steadily increased almost monthly over the past year, and the estimated sales for Fiscal Year 2024 is $76 million.” “That sales estimate, if met, would translate into more than $15 million in state and local revenue: $7.6 million from the state’s 10% cannabis tax, $5.3 million from the 7% sales tax and $2.3 million from the 3% local tax,” the station reported, noting that the Office of Cannabis Regulation “estimates that, in October alone, more than $7 million worth of recreational cannabis products were sold statewide.” Rhode Island lawmakers last year passed a bill that legalized recreational cannabis for adults aged 21 and older, making it the 19th state in the U.S. to do so. The bill, which legalized possession of up to one ounce of cannabis for adults and also permitted possession by adults of up to 10 ounces is permitted in a private home, was approved by members of the state General Assembly in May of 2022. The measure also established the framework for legal, regulated recreational cannabis sales in Rhode Island. “This is a truly momentous day for Rhode Island. I’m deeply grateful to Senator Miller for his years of hard work and leadership on this issue, and I’m incredibly proud to have been part of reaching this point,”  Rhode Island state Senate Majority Leader Michael McCaffrey, a Democrat, said after the legislation passed. “Ending cannabis prohibition helps us right past wrongs while creating new opportunities for all Rhode Islanders. This is the right move, at the right time, for our state.” The bill was signed into law by Rhode Island Gov. Dan McKee, a Democrat, who later announced that legal cannabis sales would launch on December 1, 2022. “This milestone is the result of a carefully executed process to ensure that our state’s entry into this emerging market was done in a safe, controlled and equitable manner,” McKee said last year after the sales date was announced. “It is also a win for our statewide economy and our strong, locally based cannabis supply chain, which consists of nearly 70 licensed cultivators, processors and manufacturers in addition to our licensed compassion centers. Finally, I thank the leadership of the General Assembly for passing this practical implementation framework in the Rhode Island Cannabis Act and I look forward to continuing our work together on this issue.” The Rhodes Island Cannabis Act included “a call for applications for ‘hybrid retail licenses,’” according to the governor’s office. Those hybrid licenses “allow licensed compassion centers to sell both medical marijuana as well as safe, well-regulated and competitively priced marijuana products to Rhode Island adults over the age of 21, was issued in early October,” McKee’s office said last year. Five cannabis dispensaries (described as “compassion centers” by the state) received approval from the state to open for business on December 1, 2022. There are currently seven licensed dispensaries in Rhode Island, although the state has allowed for 33 retail licenses to ultimately be awarded. Matt Santacroce, interim deputy director of the Rhode Island Department of Business Regulation, said at the time that the state was “pleased with the quality and comprehensiveness of the applications we received from the state’s compassion centers, and we are proud to launch adult use sales in Rhode Island just six months after the Cannabis Act was signed into law, marking the Northeast’s fastest implementation period.”  According to the Providence Journal, “$62.9 million worth of recreational retail marijuana has sold in Rhode Island since retail sales began last December,” although that figure “does not include sales for November, nor does it include medical marijuana sales, which are counted separately.” Including medical marijuana sales, “total retail marijuana sales in Rhode Island top $95 million,” according to the Journal. But as in other states that have taken the step to legalize adult-use cannabis, the change in law has also resulted in a dip in medical marijuana sales. Erica Ferrelli, chief of strategic planning, monitoring and evaluation for the state cannabis office, told the Providence Journal that there has been a “drastic” decline in medical marijuana patients over the last year. “Last December, 15,062 active patients bought marijuana from Rhode Island dispensaries. By October that number had fallen to 10,377,” the Journal reported. Ferrelli told the newspaper that many patients “just find it easier to transition to the adult-use market” and pay a higher tax in order to avoid “the burden of finding a doctor, getting them to sign you into the program, which is still pretty difficult, pay for an appointment and get yourself there, which for some patients might be quite the hassle.”

https://hightimes.com/

14 Enchanting Things to Do in New Mexico

Discover why they call New Mexico “The Land of Enchantment” with these activities that are geared more for smoker-friendly tourists seeking a magical adventure. Gov. Michelle Lujan Grisham signed legislation to legalize adult-use cannabis in New Mexico in 2021. Even though adult-use cannabis is legal in New Mexico, there are still laws in place regulating cannabis from seed to consumption. Speaking of cannabis, the High Times Cannabis Cup New Mexico: People’s Choice Edition 2023 is scheduled to take place Dec. 9 at the Rio Rancho Events Center in Albuquerque, with a headlining act from the iconic duo, Method Man and Redman. It’s here that anyone can be the judge to determine the best weed New Mexico has to offer. Below we list must-see attractions in New Mexico that will keep you busy during your stay in the desert dreamland, where you can see the stars in the sky and get a taste of Southwestern art. Ufologists agree that Roswell is one of the top UFO hotspots on the planet. In 1947, an unidentified craft crashed into the ground in Roswell, and wreckage from a “flying disc” was recovered on the property of a local rancher. Local, typically credible papers ran with the story. The most logical first stop is the International UFO Museum and Research Center, and the tourist traps around it. The Georgia O’Keeffe Museum is ground zero for the artist’s finest work with a collection of 3,000 pieces including 140 oil paintings, 700 drawings, and hundreds of other works. O’Keeffe was known for her powerfully direct approach to expressing the divine role of females, and she experimented with peyote. The Georgia O’Keeffe Museum  located a few blocks northwest of the Santa Fe Plaza in downtown Santa Fe. Nomads used the caves above Cliff Dweller Creek as temporary shelter about 1,000 years ago. In the late 1200s, people of the agricultural Mogollon (Southern Ancestral Pueblo) culture settled there, built rooms, crafted pottery, and raised children in the cliff dwellings for one or two generations. By approximately 1300, the Mogollon had moved on from the Gila Cliff Dwellings. Santa Fe is a very old city, especially by American standards. In 1598, the Spanish declared Santa Fe “New Spain” initially. While most of The Cathedral Basilica of St. Francis of Assisi was built in 1886, an older church used to exist on the same site, built in 1626, but was destroyed in the 1680 Pueblo Revolt. Catholic or not, this cathedral has history.  The New Mexico Museum of Natural History & Science in Albuquerque offers a fun and interactive experience. The museum’s new hall, titled Ancient Life, features hundreds of never-before-seen fossils. The Planetarium has a 55-foot Sky-Skan Definiti, full-dome theater which is great for edibles. Here you can stand in New Mexico, Arizona, Utah, and Colorado—simultaneously. The location is marked by a granite and brass plaque and surrounded by flags representing the tribal nations and states that share the region. At the site, you’ll find vendors selling homemade jewelry, pottery, crafts, and art. The cost to visit this monument is $5 per person. Got a fear of heights? According to Trip Advisor, Sandia Peak Aerial Tramway is the state’s number one tourist destination. The tram takes visitors 2.7 miles and 10,378 feet up the Sandia Mountains. You can witness views of over 11,000 square miles of New Mexico from that vantage point. Taos is home to art galleries, hot springs, spellbinding scenery and excellent skiing opportunities. Most notably, Pueblo adobe dwellings that have lasted over 1,000 years. In Taos, visitors can choose between several museums: The Millicent Rogers Museum, Taos Art Museum at Fechin House, and the Kit Carson House & Museum. With ruins that date back to 1150 CE, the Bandelier National Monument provides 33,000 acres of beautiful landscape, showing off New Mexico’s incredible natural wilderness. This includes homes carved into soft rock. You can see historical relics from the ancestral Pueblo tribes who built structures in the area for thousands of years. Petroglyph National Monument is home to nearly 25,000 petroglyphs, 90% of which are believed to have been drawn by ancient Pueblo people. Many of the meanings behind the petroglyphs is unknown. Drivers will have to pay $1 per vehicle on weekdays and $2 on weekends.  Forget the Sahara Desert: White Sands National Park is a stunning dune-filled region located within the Tularosa Basin and it happens to be home to the earth’s largest gypsum dune field. More than 73,000 acres of white sand stretch out all the way to the horizon.  Carlsbad Caverns National Park is home to over 100 limestone caves. You can choose between two underground trails, The Big Room Trail and the Natural Entrance Trail. The former is the most popular route, taking visitors through one of the largest cave chambers in North America. You can witness 400,000 Brazilian free-tailed bats exit the cave in search of food each evening.  Yet another Pueblo site, Chaco Culture National Historical Park was given its name in 2013 . No permanent outdoor lighting exists in order to protect nocturnal wildlife and the natural rhythms of humans and plants that depend on an unaltered night sky. Within the park, visitors can see evidence of the huge structures built by the Ancestral Pueblo people between 850 and 1250 AD. Or you can attend the High Times Cannabis Cup New Mexico: People’s Choice Edition 2023. A live awards show is scheduled for Saturday, Dec. 9 at the Rio Rancho Events Center in Albuquerque. The event will be headlined by Method Man and Redman, who will be joined by Devin the Dude, Paul Wall, Haizi Haze, and Lil’ Flip. New Mexico’s own will judge the cannabis and products that will prove their worth.

https://hightimes.com/

Get Tanked!

Cloud 8 has been on the frontlines of the hemp industry for years. In those years, they’ve brought an arsenal of pallet-pleasing strains to market, delivering new and innovative ways to enjoy the hemp vaping experience. With the launch of their new 3ML TANK with SmartDraw Technology™ and V-Chamber design, Cloud 8 has truly outdone themselves by creating a disposable that provides maximum power, durability, and clog reduction, ensuring a perfect pull every time. If you’ve been in the cannabis scene, there are tons of various THC disposables. Literally, tons! So, what makes the new Cloud 8 3ML TANK different? Here are some highlights and features worth discussing: After you open the new colorful Cloud 8 bag, take notice of the TANK’s feel. This disposable feels good in your hand and offers a comfortable, sleek design. The dark black casing is smooth, slick, and stylish. It easily fits in your pocket, and since the TANK has a smoothly rounded design, you won’t have pointy edges interrupting your daily activities.  A common problem with disposables is durability. Not for the Cloud 8 TANK. It’s truly armored! There will be no issues with broken canisters with the Cloud 8 TANK as it is encapsulated in what seems to be an exoskeleton of indestructible polymer. The TANK can stand up and endure a fall from mouth-height to concrete. This is a disposable that refuses to break! Hemp is very sticky and hemp disposables are notorious for clogging up. Cloud 8 has boasted that the new 3ML TANK comes with SmartDraw Technology™ which ensures you’re getting the perfect hit, every time.  They are correct!  Whether on the low or high setting, the Cloud 8 3ML TANK with SmartDraw Technology™ will provide a pull of perfection filled with robust flavor. This hard-hitting device has no issues vaporizing the distillate. Power! Another added benefit of the SmartDraw Technology™ is that it will prevent you from over-vaporization. It is self-regulated to ensure that the most optimum temperature is reached to deliver peak potency, and with each pull, a flood of flavor. Not only will you never deal with clogs, but you’ll also be able to use all the THC oil inside the device. Take some time to focus on the V-Chamber design. A clear window display will allow you to see the V-Chamber at work. The distillate inside the TANK is a beautiful, golden haze. Not cloudy. Not dark. This is important as most hemp lovers enjoy seeing the shine of their product in the same manner a wine connoisseur would inspect a fine wine sampling.  Putting gravity and engineering to work, the Cloud 8 3ML TANK’s V-Chamber design ensures you’re getting all your highly potent THC distillate.  Clicking the button twice activates the sophisticated preheat function. You’ll immediately notice that with every push of the button, the Cloud 8 3ML TANK lights up. This signifies that the preheat function has been engaged.  The light will stay lit during the warm-up and will go off when the device is ready for use. Once the preheat light is off, the TANK is ready to roll. It’s time to taste the future! The Cloud 8 3ML TANK with SmartDraw Technology™ comes with a high and low heat setting. Typically, it’s best to start low to ensure you’re experiencing all the delicious terpenes and flavonoids associated with your favorite strain; however the TANK may change your perspective, and here’s why. Click the activation button five times to cycle through the heat settings. One blink from the light on the device after a five-click cycle signifies the lowest heat setting.  Upon initial hit, the most noticeable feature will be the cool, smooth draw. There’s not a burnt aftertaste, but rather a burst of delicious flavor and herbal joy. There’s no need to “cough to get off”. Nothing but a polished pull followed by a wave of calm. One normally only gets this level of a cool smooth draw from water pipes, so to have this comfortable of a pull from a disposable is a welcomed feature. This setting would be perfect for a social sesh. With the lowest heat setting complete, it’s time to up the ante and taste the knockout power behind the TANK. Five clicks of the button will get you to the highest setting. Two blinks from the light on the TANK indicates the highest heat setting is active. Two more clicks to preheat, and off you go! Again, the most noticeable feature will be the cooling, tranquil draw from the device, however one should not underestimate the power behind the Cloud 8 3ML TANK. While taking a relatively small draw, the TANK on the high setting will produce a cloud normally only associated with high-capacity nicotine rigs. Puffy and potent, you will truly feel the maximum power behind the device.  The draw will rush a cloud of deliciously potent Delta-8 THC through your lungs, instantly sending you into a state of bliss and calm.  When getting faded is the goal, use this setting. Cloud 8 has truly heard the cries of its consumers by developing a device that brings powerful, smooth hits while ensuring you get total use of the 3ML worth of pure Delta-8 THC oil inside, all without the hassle of clogging.  The new Cloud 8 3ML TANK is poised to set the standard in modern-day hemp vaping, and consumers are ready to experience the power of the New Cloud 8 3ML TANK Disposable! Use Code: TANKTIMES for 25% Off Your Entire Order at  www.cloud8delta8.com

https://hightimes.com/

Study: CBD’s Anti-Inflammatory, Neurological Benefits Could Provide Alzheimer’s Relief

Cannabidiol, or CBD, is known and widely used for a wide array of potential benefits, including pain relief, sleep, stress and anxiety relief, its anti-seizure properties — the list goes on. While the non-psychotropic cannabinoid already boasts a number of positive effects, could preventing and alleviating Alzheimer’s disease be among them?  According to a new study, the prospects are looking strong. By 2050, the number of people over the age of 65 with Alzheimer’s could grow to a projected 12.7 million, according to the Alzheimer’s Association, underscoring the need to explore potential options to alleviate or prevent the disease. Currently, there are no cures for Alzheimer’s, though some medications can provide relief and mitigate symptoms. Alzheimer’s is progressive disease characterized by changes in the brain, resulting in distorted and lost memory along with other important mental processes over time. So where exactly does CBD fit in? Researchers from China Pharmaceutical University took a closer look at the neuroprotective and anti-inflammatory mechanisms of the cannabinoid in their study titled “Assessing Cannabidiol as a Therapeutic Agent for Preventing and Alleviating Alzheimer’s Disease Neurodegeneration,” published in the journal Cells. They found that CBD may enhance cognitive function and offer protection against the protein Aβ1–42, a biomarker associated with the onset of Alzheimer’s. ​​Aβ42 is also related to other similar conditions and symptoms like mild cognitive impairment and vascular dementia. Authors note that CBD may specifically work against Alzheimer’s, given the role that neuroinflammation plays in ongoing synaptic and neuronal damage. CBD is already well known for its anti-inflammatory properties, so researchers conducted experiments on mice to model Alzheimer’s disease using Aβ1–42. They also utilized an RNA-seq analysis to further understand some of the actions CBD may have to offer when it comes to Alzheimer’s. Ultimately, they found that CBD did not cause significant damage or cell death. Instead, CBD appeared to counteract cognitive and memory impairments induced by Aβ1–42. Researchers administered Aβ1–42 to the mice, which were then put to the Morris water maze test. This test is often used to assess spatial learning, cognitive functions and memory in rodents. Those mice treated with Aβ1–42 took longer to complete the maze, indicating increased cognitive issues. After being treated with CBD, it took mice significantly less time to escape, implying better cognitive function. CBD also helped to combat the negative impacts Aβ1–42 had on learning over a five-day period. Additionally, researchers looked at the navigation patterns of mice, concluding that CBD had the potential to boost spatial memory among Alzheimer’s models.  “Our findings suggest CBD’s efficacy in moderating microglial and astrocytic activation, offering anti-inflammatory benefits that protect synaptic function and alleviate AD-associated cognitive deficits,” authors note. “Our data support CBD’s potential therapeutic role in countering AD-related neuroinflammation.” Along with demonstrating CBD’s ability to counteract certain cognitive impairments caused by Aβ1–42, researchers said the study left them with “invaluable insights” surrounding CBD’s role in modulating critical genes within the inflammatory reaction, “underscoring its robust anti-inflammatory potential.” They also note that the equivalent dose for humans from the study is about 115 mg of CBD, which would make it a viable oral supplement. Still, researchers reference that the potential role of CBD in combating Alzheimer’s “remains conspicuously absent from contemporary guidelines.” “Our research substantiates CBD’s efficacy in either preventing or mitigating the effects of AD. Thus, future formulations of CBD supplements might be strategically positioned to include indications for AD prevention and alleviation, expanding its therapeutic repertoire,” the study concludes. While it may still be limited in the grand scheme, the exploration of cannabinoids and Alzheimer’s isn’t brand new. Denver-based MedPharm Holdings received funding in 2022 to move forward to study cannabinoids as they relate to neuropharmacology, specifically Alzheimer’s. Other research has noted the “promising” potential that cannabinoids like CBD hold when it comes to Alzheimer’s and dementia-related symptoms, specifically citing findings in rodent models showing the effect of cannabinoids in reducing amyloid plaque deposition and stimulating hippocampal neurogenesis. A Toronto-based biotech company is also researching the potential of new pharmaceutical formulations of the psychedelic drug Dimenthyltryptamine (DMT).

https://hightimes.com/

California Man Charged with Manslaughter Over “Slapping Therapy” Death

A California man has been extradited to the U.K. to face manslaughter  charges over the death of a woman at his 2016 slapping therapy workshop.  An investigation was opened in October, 2016 when 71-year-old Danielle Carr-Gomm was found dead in her hotel room at Cleeve House in Seend, Wiltshire. Carr-Gomm had recently attended a paida lajin retreat, which is a form of therapy from China wherein a person vigorously slaps certain parts of the body in order to expel certain toxins from the blood.  60-year-old Hongchi Xiao, a man from California who was in Australia at the time of his extradition, was held and questioned in the U.K. in 2016 along with two other men in relation to Carr-Gomm’s death. “Hongchi Xiao, 60, of Cloudbreak, California, returned to the United Kingdom from Australia on an extradition warrant and has been taken to Gablecross custody in Swindon where he was charged. This relates to the death of Danielle Carr-Gomm, 71, at Cleeve House in Seend in October 2016,” said local police to the Guardian.  According to a BBC article on the subject of paida lajin, the head and joint areas of the patient are repeatedly slapped until they turn red or bruised. This is based around the ancient Chinese belief in “sha,” meaning that “toxins” from the blood vessels which appear during the course of paida lajin therapy in the form of redness or bruising at the slapping site are a sign of latent disease. Critics of this practice have pointed out, somewhat redundantly, that this is just the result of blood vessels breaking and skin bruising.  According to ABC Australia, Xiao was previously investigated over the 2015 death of a seven-year-old diabetic boy in Sydney, Australia who had previously attended one of his workshops. Xiao received a 10-year sentence for his involvement in the boy’s death in 2019. An investigation revealed he told the boy’s parents that the boy would not need insulin or medical treatment for his diabetes if he attended the slapping therapy. An Australian news outlet reported in 2022 that Xiao’s charges had been overturned after he appealed his case on the grounds that the evidence presented was inconsistent. He had served six years of his 10-year sentence at the time, and was out of jail a little over a year-and-a-half before his extradition  Matthew Carr-Gomm, Danielle’s son, told the Guardian that his mother was diabetic but had difficulty injecting her insulin due to a fear of needles, thus leading her to seek holistic methods to treat her ailments.  “She was always keen to try and find alternative methods of treating and dealing with her diabetes and was very interested in alternative and holistic medicine and therapies. I know she was desperate to try and cure herself of this disease. She always maintained a healthy lifestyle and was adamant that nothing would stop her from living a full life,” Matthew said. “In recent years, mum was in a great place with a partner, a lovely home, and was traveling the world. She had a lot of life left in her.” A BBC reporter with a knee injury actually reported on her firsthand experience attending a paida lajin workshop in 2015, though she was actually beaten with bamboo sticks instead of slapped.  “He felt around my knee for where he thought the “little clots” were and without warning, forcefully whacked my knee. He aimed for exactly the same spot each time. It was excruciating. I yelled in surprise. The bruises turned purple quickly and minutes later, I had to halt the blows,” said BBC reporter Pamela Koh. “The beating needed to continue for at least 20 minutes to be effective, I was told. I gritted my teeth between the sharp, swift blows but I had to tell him to stop. He resumed until it became unbearable again and I tried to sit through the full 20 minutes of pain.” Incidentally, Koh reported that her knee eventually did get better but that the bruises took weeks to heal properly and she was unsure if her knee got better because of the therapy or because of the body’s natural ability to heal. A video of Xiao demonstrating paida lajin therapy can be found at this handy dandy little hyperlink. He was charged with manslaughter by gross negligence upon his return to the U.K. It was not immediately clear how much prison time he faced if convicted. 

https://hightimes.com/

New Jersey Launches Second Phase of Cannabis Seed Equity Grant Program

The New Jersey Economic Development Authority (NJEDA), an agency responsible for providing financial assistance to New Jersey-based businesses, recently announced that it will now be accepting applications for Phase II of its cannabis equity seed grant program. This phase includes a total of $8 million that will be split up between 48 applicants ($150,000 each). The entirety of the Cannabis Seed Equity Grant Program offers a total of $20 million to applicants with either a conditional or annual cannabis license, with the goal of providing funds for start up and operation expenses during a business’s first three years. The first phase of the program allocated only 40% of funds for social equity applicants, whereas Phase II is utilizing 100% of reserved funding for social equity purposes. The application window for Phase II opened on Nov. 30 at 10am, and approved applicants will receive $150,000 and “no-cost technical assistance,” which includes an eight-week program for grant recipients to benefit from in the form of webinars. “The technical assistance program will provide training on converting a conditional license to an annual license, building a cannabis business team, financial management, securing investors, supply chain management, and more,” NJEDA stated. According to NJEDA Chief Executive Officer Tim Sullivan, building out this program will bolster the state’s cannabis industry. “Under Governor Murphy’s leadership, New Jersey is on the forefront of creating a stronger and fairer cannabis market, especially for communities historically harmed by the unjust War on Drugs,” said Sullivan. “The Seed Equity Grant, which is specifically designed for social equity applicants, will help create an equitable, inclusive marketplace that will create jobs and strengthen communities, all while ensuring our entrepreneurs are able to reap the industry’s economic benefits and have access to the resources needed to succeed.” The Cannabis Regulatory Commission (CRC) also signed off on the effort to prioritize social equity. “We are excited to see grant funding being used to help social equity applicants realize their entrepreneurship dreams. Beyond the skills and business acumen it takes to be an entrepreneur in any industry, starting a cannabis business faces additional challenges—including limited access to traditional means of business funding,” said CRC chair Diana Houenou.  Phase I applicants were not required to have secured real estate or municipal approval for their cannabis business. For Phase II grant applications, applicants must meet all CRC criteria as well as have already obtained a conditional license. According to the NJEDA website, the most recent application window was so popular that by Dec. 1, new applicants were placed on a waitlist. “Based on significant interest in the Cannabis Equity—Seed Equity Grant, the NJEDA has already received applications up to or exceeding the amount of funding available under this program,” the agency posted on its website. “All submitted applications that are received at this time will be placed on a waitlist and will be reviewed if the NJEDA can determine there is funding available to support the application.” Recently in October, NJEDA announced $12 million in funds for 48 cannabis business applicants ($250,000 each), describing the round as one of the largest social equity grants of its kind in the U.S. Gov. Phil Murphy spoke about how essential it is to invest in social equity applicants. “As the cannabis industry continues to reach new heights in New Jersey, it is important that we build on our efforts to support the businesses seeking to enter and grow within this emerging market. The Cannabis Equity Grant Program allows us to simultaneously expand the pool of cannabis businesses in our state while also focusing on those communities most impacted by the unethical War on Drugs,” said Murphy. “As we work to create a stronger, fairer, and more equitable cannabis market, our Administration will continue to increase access and opportunity to the small businesses entering the industry.” Also in October, Murphy and Attorney General Matthew J. Platkin announced that $5.5 million in cannabis tax funds would be put toward the New Jersey Hospital-Based Intervention Program. The money comes from the Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Fund, with a goal of support victims of crime through crisis intervention and victim compensation. The $5.5 million will be granted to eligible applicants starting in 2024. A poll conducted earlier this year in May by Stockton University showed the changing attitudes of cannabis in New Jersey. Out of more than 660 participants, one-third of them said that they’ve used cannabis since it was legalized. Forty-four percent said that they used cannabis for recreational purposes, while 39% said it was for both medical and recreational purposes, and only 13% said they tried cannabis for medical consumption only. The poll showed that 69% of consumers purchased their cannabis products through a legal dispensary, and 86% of them said that they were “satisfied” or “very satisfied” with the experience. However, with the state having some of the highest cannabis prices in the country, only 7% of participants said that they approve of current cannabis prices.

https://hightimes.com/

Oregon Weed Glut Continues in 2023

Oregon cannabis producers grew too much weed again this year, according to a new report, continuing the glut of marijuana that has plagued the state’s regulated pot industry for years.  For much of this year, analysis of Oregon’s production of cannabis showed that the state was on a downward trend compared to last year, leading to a modest increase in prices. But a new report from state economists Mark McMullen and Josh Lehner that was released on November 20 shows that this year’s fall harvest of outdoor weed pushed this year’s total crop beyond production levels posted in 2022. “Through the first nine months of the year, the marijuana harvest was nine percent lower than a year ago, and 15 percent lower than the record crop back in 2021,” the economists wrote. “As the market appeared to be adjusting, prices were stabilizing. That changed with the large October outdoor harvest which is 15 percent larger than last October.” Oregon’s cannabis cultivators have been growing more weed than the state’s consumers can smoke for at least five years. Mark Pettinger, a spokesman for the Oregon Liquor and Cannabis Commission (OLCC), said last year that the problem is caused in part by the difficulty operators and regulators have in predicting weed production. Because much of the state’s weed is harvested at the same time, the industry can be slow to adjust to changing market conditions at the wholesale and retail level. “It’s because about 85% of the crop is grown outdoors, comes down in October during harvest time, but planting planning is made the following April — which there really hasn’t been enough time to really gauge how the harvest from the previous fall is impacting the market,” Pettinger told a local television news outlet in 2022. The glut of weed in Oregon’s regulated market has wreaked havoc on the industry for years. Because of the oversupply, prices on wholesale cannabis and retail products have plummeted. While the decline in prices is welcomed by most consumers, cannabis companies have been left with dwindling margins and falling, or nonexistent, profits. As a result, producers, wholesalers and retailers throughout the state are having a difficult time making ends meet. Beau Whitney, a Portland-based economist who monitors cannabis prices in Oregon and throughout the United States, said that more than one-third of respondents to a cannabis industry survey said that they are having difficulty paying their taxes. Even more said that managing debt is a problem.  Whitney said that the latest report of Oregon’s abundant fall harvest “couldn’t have come at a worse time.” “People are walking away from cannabis licenses or selling them for pennies on the dollar,” Whitney told Willamette Week. The slump in cannabis prices has also been reflected in the collection of Oregon’s weed taxes. Throughout the state, tax delinquencies are up and cannabis tax revenue has fallen short of estimates for four of the past five quarters. Whitney noted that Oregon regulators could spur an increase in cannabis prices with a curb in production, which could be accomplished by limiting the number of licenses or their capacity. But Pettinger of the OLCC said that the current oversupply conditions are the result of intentional policy decisions coupled with the federal government’s continued refusal to legalize cannabis, which would open up markets across the country for Oregon’s weed growers. “The state and the industry and elected officials envisioned Oregon becoming a net exporter under federal legalization,” Pettinger says. “The oversupply we’re seeing underscores the dilemma in all states where marijuana is legal—it’s the equivalent of an Iowa corn farmer only being able to sell his crop within Iowa.” Falling weed prices and the resulting instability of Oregon’s cannabis industry led two industry groups to join forces in a recent merger. The two groups, the Oregon Cannabis Association and the Cannabis Industry Alliance of Oregon, announced the merger last month following unanimous votes by the boards of directors of each organization.  “There’s a lot of knowledge, there’s a lot of passion, there’s a lot of really educated folks within the cannabis industry in Oregon,” said Hunter Neubauer, board member of the combined trade group. “Those folks need one place to go to, where they can take a little bit of money that they have, and hopefully become members, and show up with us in Salem and advocate for reasonable regulations and future opportunities for the industry.” The newly merged group is named the Cannabis Industry Alliance of Oregon and represents more than 500 member businesses in the state’s licensed cannabis market, which generates about $1 billion in sales annually. “It’s a community that we all really value and we want to see survive and thrive,” Mike Getlin, the board chair of the Cannabis Industry Alliance of Oregon, told local media. “We want something more than a bunch of minimum wage jobs owned by out-of-state and potentially even overseas financial interests. So that’s what this fight is really about for us.”

https://hightimes.com/

Man in Minnesota Offers Free Grow Classes to the Public

A man in Minnesota is providing free growing and cannabis basics workshops—free to the public—to help people get a foot in the door of the industry. Minnesota allows home cultivation under its recently approved adult-use cannabis law, and residents are eager to see if they have a green thumb. Minnesota adults are allowed to grow up to eight plants, four mature. Growing cannabis takes years of experience to master, but you gotta start somewhere.  Inforum reports that Steve Rosenfeldt, who is the owner of Ediblez OTC in Moorhead, Minnesota, wants to share his expertise with the plant to others. Rosenfeldt is hosting monthly Cannabis 101 and Growing 101 Workshops, held on the last Tuesday of each month at the Midtown Tavern in Moorhead. Locals say the skills they’re picking up will be valuable. “Really nice to be able to learn how to grow your own and not have to go to the store,” Jamie Carrillo, who was one of 40 people to attend the most recent workshop held on Nov. 28, told Inforum. Inforum reports that it’s the third class Rosenfeldt has taught so far. Each class attracted dozens of curious would-be growers of all ages, and some are reluctant to grow due to the lingering stigma surrounding pot. “There’s still a lot of stigma, people are skittish of even being seen in here, so it was kind of a surprise to have as many people turn out,” he said. Rosenfeldt is legally allowed to sell seeds that can grow cannabis at his store, but he cannot yet sell marijuana products. The store instead sells hemp-derived CBD and THC products. The seeds cost around $30 or $40, and it takes about four months for the seedlings to become mature plants. Last May, Minnesota Gov. Tim Walz signed the state’s cannabis legalization bill into law, officially making Minnesota the 23rd state in the nation to legalize recreational cannabis. The 300-page bill allows adults in the state over the age of 21 to use recreational cannabis and looks to transform the current illicit market into regulated, state-licensed businesses around the state. It specifically creates a new regulatory framework to license cannabis businesses to cultivate, manufacture and sell cannabis at retail dispensaries. There are a total of 12 different business licenses a person can apply for in the recreational market, along with additional licenses for medical cannabis. The legislation also expunges low-level cannabis convictions. The new law will automatically expunge non-felony cannabis offenses, and it will establish a board to review more serious cannabis crimes. The bill was designed with social equity in mind, granting social equity status to military veterans or active service members denied honorable status because of a cannabis offense, farmers from underrepresented communities and residents of areas which have “experienced a disproportionately large amount of cannabis enforcement.” The industry is overseen by the Office of Cannabis Management, which controls the regulation and sale of cannabis products in Minnesota. When Minnesota legalized cannabis for adult use, it set the home limit at 32 ounces or 2 pounds. But out in public, Minnesota adults are allowed up to 2 ounces. The legislation allows adults to grow up to eight cannabis plants at home, including four mature, flowering plants. Out of the states that have legalized cannabis for adult use, the limit for personal amounts at home in some states ranges from 1-10 ounces. Most states with home cultivation don’t have any limits set. “The vast majority of adult use states that allow home cultivation don’t have any explicit limit,” NORML Political Director Morgan Fox told High Times at the time. “And most of them explicitly say that you can keep whatever you grow in your own home. There are four states aside from Minnesota that actually have set limits. Massachusetts has 10 ounces, Michigan has 10 ounces, Oregon is eight ounces and New York is 5 pounds.” “If you’re gonna put a limit on it, I think it’s a good idea to have it towards the higher end of the spectrum and possible so that you can avoid potentially criminalizing people that are growing their own medicine or growing cannabis for their own purposes, but who are trying not to transfer to anybody else, you know, they’re not trying to gift it out, and certainly don’t want to be selling it. Local business owners in the area, however, said that they predict 99% of consumers in the state aren’t going to have a need for 2 pounds of cannabis at home, and if they do, they will probably sell it illegally.  Despite having the higher limit, industry insiders say it’s not enough for the state’s four-plant home grow limit.

https://hightimes.com/

Planted in the Culture

As cannabis came out of the dark ages, brothers Daniel and Bryan Eatmon, aka Old E and Bleezy, of Mendo Dope gave the world one of its first insider glimpses into the Emerald Triangle. Sure we had Weed Wars, a limited reality show series that debuted in 2011, but not long after, Mendo Dope started giving us an authentic look at the hill in between the tunes and very reputable cannabis they were growing. Old E and Bleezy popped their first cannabis seeds in the valleys of Mendocino County, California in 2006. That was still very much the dark ages of the Bush administration era, but compared to what was going on in the neighborhood they didn’t have a lot to worry about with their single plant. “It was in our mom’s backyard. From there, we gradually got to grow a couple more plants the next year, and a couple more plants for the next year, until we really got our own spot and were able to do our first patch,” Old E told High Times. “It was like 12 or like maybe 15 plants.” As they continued to get more dialed in, the plant size jumped before the plant count did. Many people considered that the safer course of action back in the day. They would start growing the monsters that they have become famous for over the last 11 years, starting in 2012. During all this development on the cannabis side, things were also pumping along on the music side as they shared the culture they were raised in through their tunes. “The tunes and the cannabis have been side by side from the beginning,” Old E said. “Back before we grew our first seed I was into freestyling with some friends back in high school, working on a little bit of music and such. But our first actual underground album, NOYB Boys, came out in 2007.” Their debut album featured photos of their first grow. The duo still remembers the seeds for those first plants well. “It was out of a bud that we got from somebody that was kinda unknown,” Old E said. “We didn’t even know what the strain was. When we harvested it, it was a really dark purple strain. It was beautiful. It’s one of those strains where you’re like, man, I wish we knew what we were doing back then. We could have saved the clone because we didn’t even have any idea what we were dealing with. But it was some really killer stuff. We just called it Backyard Purp.” But pretty soon they were far removed from that one plant. By 2012 they weren’t just growing monsters in huge pots but had also maxed out their plant count to 25. At the time, that was the medical limit in Mendocino County and considered “the number” if you were going to play it safer than some of the bigger gardens or properties with multiple gardens spread across them. They crushed it in 2012. But they were already at the 25-plant limit. They went into 2013 with the same plan, continuing to cultivate in their new spot in Mendo. The count remained the same, but the plants got even bigger. “So the next season 2013, we lose our biggest garden up to that date. It was killing it. We’re having so much fun. It was when we first got to start hanging out with Subcool and filmed for The Weed Nerd. And that was the year that we got raided,” Old E said. “You know it took all this time to build up to finally have this epic garden. That was the biggest one we had. And they chopped it all and took it away from us.” That 25-plant garden was supposed to be a legal medical grow. All the paperwork was in order as far as Senate Bill 420 was concerned and the Attorney General guidelines that were released in 2008. The bill and guidelines provided growers with the best roadmap to being compliant at the tail end of California’s medical era. “The house that it was at, it was definitely not out in the hills. It was really close to the freeway. It was in a residential area. So we had a couple of houses that borderline right on our fence line,” Old E said while noting that the neighbors weren’t the issue. “And so it wasn’t an ideal spot to have a whole backyard full of greenery, but we were operating under the laws and under guidelines as well. We are under the impression we were operating in compliance with everything.” Thankfully the duo had already started making a name for themselves in the wider cannabis community at that point and the community was there to support them. Old E couldn’t emphasize enough how awesome it was watching people help them get back on their feet because they knew they shared the love of the plant with them. Subcool would play a big role in helping get word out about the situation. “We had weed nerds reaching out from all over the place. I mean, out of the country, people all over the states and they just wrote us and say, ‘Hey, man, you guys need anything? I can send you guys some seeds if you guys need some herbs,’” Old E said. “People were sending us care packages left and right. And it was like such a boost of energy and just positive vibes and that made us like survive through the struggle because we had put everything into the garden. And we lost everything.” The raid happened at the end of the season on Oct. 10. Commonly referred to as Croptober in the Emerald Triangle, the state agencies that came were looking for the biggest plants possible. They make for the best photo ops. In the process of the raid drama and then starting over with a small personal patch at the family home to get things going again, the duo realized they wanted to spend more time helping people understand that they were growing these monster trees organically. The pair thought if they can grow six plants without law enforcement messing with them that they should. But they wanted to grow absolutely massive plants, film it all, and show other people exactly how they did it. “So that’s what kind of started off the whole How to Grow Mendo Dope series that we did on YouTube, which led to actually filming a couple of How to Grow DVDs. And it just started just coming back into growing very small gardens but doing big plants,” Old E said. As this was all going down, they were starting to see the writing on the wall that legalization was right around the corner. The pair’s first impression was that it looked pretty scary. They knew it was only a matter of time before big corporate entities with plenty of resources and money were coming. “Small farmers like us that have been up in the mountains, not a lot of us are just like sitting on a lot of money,” Old E said. “We love this plant so much and we helped so many people with it. And it’s our job. We’re farmers, you know, so this is a circle of things that we put back into the community, living off the land and supporting ourselves with farming. So we knew that this was about to be a very tough transition.” They knew plenty of people that didn’t want the cannabis industry to go legal. And they knew when it did get legalized, it wasn’t likely to be in a way that worked for everyone. They understood that cannabis wasn’t being legalized so farmers could make more medicine, it was so people could make money. Old E and Bleezy didn’t plan on being caught off guard or missing out on the moment. They prepped for it by trying to build out their brand to show people what they were all about. “We wanted to stay true to what we were doing and who we were and we wanted to let people know that we’re going to always be doing it this style,” Old E said. “This is why we’re in this game. Because we have a love for the plant. We have a passion for this and this true natural medicine. So we just started to take people into our life, into the culture that we represented, that we live. We’re submerged in it out here. So we just started kind of building our Mendo Dope brand and showing people who we were and what we’re all about.” During all those trials and tribulations, Mendo Dope music continued to pick up. They found themselves back on a firm footing by 2015. They would release their Live in the Garden album, which was recorded in the garden, that year. Mendo Dope kept picking things up between 2016 and 2017 as the implementation of Prop. 64 edged closer and eventually, they got the garden back up to about 20 plants. While their property was dope, the particular residential zoning they found themselves in wouldn’t fly for a legal farm. They weren’t looking for a mountainside or an acre, they just really wanted to be able to grow at home. The news was brutal. Back then when people received that kind of news they had three options. The first was to pick up and move. There are certainly folks that changed their lives a lot to get a property they could grow at. The second is just to keep pumping it on the underground market. Most of the small- to medium-size growers still in the underground haven’t had a lot of problems post-legalization haven’t had a lot of problems. The third and final option was to just give up. Mendo Dope was not going to give up. They decided to work in collaboration with Greenshock Farms for a few years. During all this they also started their breeding program in 2017 after Subcool bred their own strain for them. During a conversation with Subcool in 2016 they mentioned that they had found a Locomotion pheno that they believed was the right lady to get things going. But they weren’t sure what direction they wanted to head in with the male, and Subcool recommended using his Querkle male. “We were intrigued right away and were like ‘Let’s get it going,’” Old E said. “We created the Mendo Dope with Subcool. That was our very first intro into breeding, our first strain, and it really opened up our minds. It was so fun and it was so exciting breaking down these buds and hearing all these seeds hit the table and then growing them out and finding phenos.” This was their creation and they felt like it was taking their personal experience to a whole new level. Sadly, much of the stockpile of seeds was lost when Subcool’s home was destroyed during the wildfires of 2017 that devastated Northern California, but Mendo Dope wasn’t going to let the fire stop their breeding goals. “We knew we had to get back on it,” Old E said. “We got some Querkle seeds, we popped them, we found a new male and we did it again. And this time we created them at our house in our indoor room and we had the first batch of Mendo Dope seeds that we did all at our own spot actually. I believe that it had to be 2018.” These days Mendo Dope is still growing on the same hill they moved to after first leaving the valleys of Mendocino for its higher elevations. We asked what the differences were between cultivating in Mendocino’s different microclimates. “Well, the valley is a lot hotter. I mean, it was definitely a big change in the temperature. And down in the valley we get no coastal breeze at all, you know that shit burns off before it comes down that final hill to us,” Old E said. “So up here it’s really cool. Like, just the climate is definitely different. Certain strains that we’ve actually grown down the valley and ended up here. It’s really cool to see how different they perform only being 40 minutes away from each other. There are so many differences in strains when you grow [them] in different locations. It brings out different characteristics and different terpene profiles with the soil that it’s in, [and] with the root system that it’s intertwined.” Expect Mendo Dope to have a massive year in 2023. Their 2022 phenohunt will serve as the building blocks of their attempt to get Mendo Dope flowers into the hands of more people, coming off a terpene award in association with a concentrate made from their flowers at 2023 Emerald Cup where science dictated they had the best terps in the world’s premier cannabis contest. They also plan on dropping their next album Planters of The Trees 2 on Oct. 10, the 10-year anniversary of the raid. This story was originally published in the October 2023 issue of High Times Magazine.

https://hightimes.com/

Beastie Mode

Mix Master Mike shot the intro scene to the Beastie Boys’s “Three MCs and One DJ” video 10 times over the course of eight hours in 1998. He would begin by walking from a coffee shop in New York City to the Beastie Boys’s “secret” rehearsal space—which he says was “basically a dungeon”—wearing a Ghostbusters proton pack he’d picked up from a Hollywood prop shop and a NASA spacesuit. MCA (Adam Yauch), Mike D (Michael Diamond), and Ad-Rock (Adam Horowitz) didn’t expect that, but this was Mix Master Mike’s first video with the Beasties and he wanted to make an impression.  “They had no fucking idea I was coming in with that,” Mix Master Mike tells High Times.“To see their faces when I walked in with that jetpack for the first time, they were like, ‘Yeah, he’s awesome.’ I needed something that was gonna stick in everyone’s minds.”  It took Mix Master Mike, whose real name is Michael Schwartz, almost two minutes to walk from the coffee shop and down the six flights of stairs to the room where Beasties were patiently waiting for him to put the needle on the record. Mike later found out they ended up using the first take, which makes him wonder if the nine extra takes was their way of hazing him. After all, these are the same guys who toured with a giant inflatable penis during the Licensed To Ill era and essentially made debauchery into a full-time (and very lucrative) job. But Mike didn’t care—he was just happy to be along for the ride. Mix Master Mike, a founding member of the Invisibl Skratch Piklz turntablist crew and DMC World DJ Champion, was crab scratching his way into becoming the fourth Beastie. When he was asked to contribute to 1998’s Hello Nasty, the trio’s fourth studio album, he seized the opportunity to really show them what he could do. It would prove to be one the Beasties’ biggest albums, debuting at No. 1 on the Billboard 200 with more than 681,000 copies sold in its opening week. It was almost like the Beastie Boys were getting a second chance.  Following the juggernaut that was Licensed To Ill, the Beastie Boys next two albums—Paul’s Boutique (1989) and Check Your Head (1992)—didn’t quite have the same impact as their predecessor. In fact, Paul’s Boutique was considered a “flop” upon its arrival. But by the mid-’90s, it seemed they started to hit their stride again. Ill Communication, released in 1994, landed at No. 1 and the Beasties were back on the proverbial top. Hello Nasty took it to an astronomical level, but Mike never anticipated that kind of success. “I didn’t really think about none of that,” he remembers. “When I was in the studio with them, I was just liking what we were making. I was liking every song that we made and I was just like, ‘Man, this is awesome. I’m in a fucking dream right now.’ I just didn’t know it was gonna come with all this extra shit until we until we did the first show and I was like, ‘Oh fuck. This album is huge.’”  Mike was also busy promoting his own solo record, Anti-Theft Device, and he admits it was “a lot to take in.”  Hello Nasty turned 25 on July 14, so Mike has been reflecting on the making of the album more so than usual—despite having the platinum plaques in his house as constant reminders. Mike, a San Francisco native, holed up in New York for a month while they were recording it—and cannabis may or may not have been consumed along the way (wink).  “There might have been,” Mike says. “There were times when we would go out on the balcony, and I mean, some of it was heavily weed influenced, but it was just more internal excitement on my end that we were together. But yeah, there were a lot of joints, a lot of Zig-Zags [laughs]. I don’t know, but they probably smoked when they wrote ‘Three MCs.’ I remember being in the studio with Mario C [producer] when we did all the tracking for ‘Three MCs,’ and the guys disappeared. They said, ‘OK, we’re gonna go drive around and write lyrics.’ They probably did smoke. When they came back, they were [rapping], ‘I’ve got the D double O, D double O style.’”  At the time, Mix Master Mike wasn’t exactly a member of the Beastie Boys—at least not yet. DJ Hurricane, who began DJing for the group in 1986, was still considered part of the crew and heavily involved in the creation of both Check Your Head and Ill Communication. At one point, they had to have a serious conversation with both DJs.  “It’s kind of like a situation where after the Hello Nasty recording session, the guys brought me into one of the sound rooms,” he recalls. “We all sat on the floor and it was me, Adam, Adam H., and Mike. They were so happy with how the process came about and they asked me to become their DJ in that moment.”  But then Mike’s thoughts turned to DJ Hurricane—what would they tell him?  “I was just like, ‘Oh shit,’” he continues. “Being the empath I am, I was like, ‘What about Cane?’ And they’re like, ‘Don’t worry. We’ll tell Cane. I’m like, ‘OK cool.’ It was a situation where I said I was gonna take them to the next level when it comes to this department [DJing]. A couple of weeks after that session, they called Cane and let him know. I’m sure he was pretty heartbroken, but they told me Cane was more into rapping and was working on a solo album, so he’d be OK.”  Mix Master Mike wound up contributing to 2004’s To The 5 Boroughs, 2007’s The Mix-Up and 2011’s Hot Sauce Committee Part Two. Between The Mix-Up and Hot Sauce Committee Part Two, MCA was diagnosed with cancer. In 2012, Beastie Boys were inducted into the Rock & Roll Hall of Fame, but MCA was too sick to attend.  “We really didn’t care, like none of us really cared about it,” he says. “We’re just going with it. Actually, the boys were gangster about that situation. They were asked to be part of the Rock Hall two, three years prior, and they denied it. I thought, ‘Wow, you guys are probably the only dudes that have denied the Rock & Roll Hall of Fame honor. It was gangster.”  MCA died a short time later on May 4, 2012, leaving the Beastie Boys in shambles—not just because the Beastie Boys would now cease to exist as a hip-hop group but because they lost their best friend. Over the last 11 years, Mike D and Ad-Rock haven’t made any more albums as the Beastie Boys, but they did release the Beastie Boys Book in 2018 and the accompanying documentary, Beastie Boys Story, in 2020. Mike, in the meantime, has done massive stadium tours with Metallica and Godsmack, released a slew of projects—both solo and collaborative—and is currently working on a documentary about his journey.  “I’m just working,” he says. “I’m working on scoring my documentary and getting and compiling all this footage. I’m getting my story together and doing an audiobook as well. I made 70 tracks during the pandemic, so I’m sitting on three or four albums right now. I’m just waiting for the right time to release them. But it’s crazy because my story just keeps going. I’m not done here.”  This story was originally published in the October 2023 issue of High Times Magazine.

https://hightimes.com/

A Love Letter to the Macrodose

This is a love letter to large things. Microdoses are for tourists.  Sometimes, tourists love a place so much that they move there. As a white girl from the Caribbean, I (and my parents) can certainly understand that.  I think fellow High Times writer Hadley Tomicki said it best in the article that is art titled “In Defense of Macrodosing” with the words (the whole essay is worth a read), “many of us entered the world of cannabis when all we had was a tin can and some dry buds the color of Hershey cocoa.” Younger stoners grew up in a world of millennial pink Indica vape pens, CBD lavender edibles blended with other aphrodisiacs, and multi-course infused dinners, low-dose, of course! Other older folks are putting behind their regressive views and embracing cannabis, but, honestly, kind of screw you if you needed daddy government’s permission to enjoy grass, if that terminology even applies anymore. Consider donating to The Last Prisoner Project if you have enough dough to shell out $120 for a box of dainty edibles clocking in at 2.5mg of THC per serving.  But it’s true that it’s best to “start low and go slow” if you’re new to cannabis. Otherwise, you could risk gobbling down an entire 100mg brownie and trip for 24 hours, unsure if the Wookies around you are real or part of a dream, so you zip yourself up in your hot tent in West Virginia and start having spontaneous orgasms. Like what happened to me in college at a music festival, transforming me into a sexy stoner, like when that radioactive spider bit Peter Parker, transforming him into Spider-Man. Maybe you should have that experience now that I write it out. And I actually have no idea the THC content of the infamous brownie because I got it from a couple tattooed with the THC chemical structure who baked it themselves and just wanted to give ’em out. Once upon a time, the idea of THC dosage printed on a label was absurd.  But enough about sounding old. I’m a hot girl. And I won’t say that macrodosing is “empowering” because, as we’ve established, I got my power from happy hippies at a music festival (and describing women as empowered is just so infantilizing). But there is something about popping back a big one with my best friend before we step out of the subway in our stilettos and click-clack towards the party. Maybe it’s because the devil’s weed is a woman. And, regarding the subway, now’s my chance to blame the macrodose on criminalization. Why did I get into THC gummies? They don’t smell; I can say that they’re candy, and as a result, especially before New York went legal, I feel safer carrying my enhanced sugary delights than a bag of flower.  There are plenty of logistical reasons to argue in favor of the macrodose. It’s more bang for your buck. Companies might be trying to rip us off under the guise of low-dose, as Jimi Devine detailed in “The Great Cannabis Microdosing PR Conspiracy.” The medical marijuana world has been advocating higher THC doses forever. There’s some pain that 2.5, 5, or even 10mg won’t touch. The current cannabis dosing also doesn’t adequately consider the vast differences in bodies. As Tomicki writes, many of us grew up with the plant and now have higher tolerances. And sure, THC can be ingested to avoid emotional pain that one should probably be handling straight on and addiction exists. But I come from a harm reduction perspective. I think the idea that there is morality to sobriety or honor in suffering is absurd. It’s a medicine, and for many people, the line between medical and recreational is blurry. Would you rather I take an opioid for this migraine pain that makes me barf or opt for the plant that also handles nausea? Would you unclutch your pearls if I cut loose with tequila shots instead of a goofy gummy bear? Come on.  But the best reason to adore the macrodose has nothing to do with logistics. The sugar-dusted 100mg gummy bear wants nothing to do with practicality. Because the best argument in favor of the macrodose is just that it’s fun. The more appealing argument for getting totally baked is that, at least for some of us, it’s frilly, frivolous, fun.  Because yeah, low-dose aphrodisia edibles are cool, but when was the last time a micro-dose gave you spontaneous orgasms? 

https://hightimes.com/

Germany Eyes April 2024 for Cannabis Legalization

The Germany’s coalition government called the Traffic Light coalition, which combines individuals from the Social Democratic Party, Free Democratic Party, and The Greens, reportedly reached an agreement for cannabis regulation on Nov. 27. These recent discussions estimate that cannabis legalization could take effect starting on April 1, 2024, with social cannabis clubs potentially allowed to open as early as July 1, 2024. “The #Cannabis law is coming! Finally: We are finally ending the failed ban policy! After intensive negotiations, there is now a law that focuses on youth and health protection , ends criminalization and is practical,” said The Green Party spokesperson Kirsten Kappert-Gonther in a translated social media post. According to news outlet Deutsche Presse-Agentur (DPA), Kappert-Gonther said that the coalition has come to a consensus regarding possession and cultivation. With legalization, residents will be permitted to grow up to three plants at home, and have no more than 50 grams from cannabis cultivated at home (up from 25 grams in previous discussions). Cultivation will not be permitted within 100 metres (approximately 328 feet) from places where children frequent, such as daycare businesses, playgrounds, and schools. “In the negotiations, we have succeeded in finding practicable regulations that guarantee the protection of young people and health and make the decriminalization of adult users a reality,” said Kappert-Gonther. While possession of more than 25 grams was the initial threshold for criminal conviction in an early draft, now people are allowed to carry 25-30 grams of cannabis in public, and 50-60 grams in private. Any more than these amounts is still considered a criminal offense, with fines of up to €30,000 ($38,000 USD). Previously, the fines were set to a maximum of €100,000 ($126,930). DPA reports that the German Federal Ministry of Transport and Digital Infrastructure is expected to propose a THC limit for impaired drivers by the end of March 2024 as well. “Communal consumption in cannabis clubs and edibles is not (yet) implemented,” Kappert-Gonther added on social media. “But what we were able to agree on together is a big step forward. Thank you to everyone who has campaigned for this law for decades!” Currently the law is still a draft and subject to change, but the next step includes sending the current draft to the German Bundestag, or parliament, which could happen as early as next week. The Bundestag is separate from the German Bundesrat is a separate governing body that represents the country’s 16 states. The resolution of cannabis legalization has been a long time coming in Germany. The Traffic Light Coalition announced its intentions to work together to legalize adult-use cannabis back in November 2021.  Health Minister Karl Lauterbach, who had previously opposed cannabis legalization, shared that he had revised his opinion in summer 2022. By September 2022, Lauterbach announced that there would be five hearings to discuss cannabis legalization. “We are starting the preparatory phase of legislation. Being able to finally announce this is a special, gratifying moment for me personally,” Lauterbach said at the time. “Like many others, I have been working for years to ensure that we in Germany finally stop criminalizing cannabis users and start a modern and health-oriented cannabis policy.” Earlier this year in April 2023, AP News reported that a scaled-back version of cannabis social clubs was being proposed. By July 2023, Germany officially revealed the details of its draft bill. “It is planned to pass the draft law in the federal cabinet during the summer break. The draft law will then be introduced into the parliamentary legislative process and discussed in both the German Bundestag and the Bundesrat in the autumn. The German Bundestag is responsible for the final decision on the law,” the Germany Ministry of Health stated. “The law does not require the approval of the Bundesrat. It is scheduled to come into force at the end of 2023. Once the bill comes into force, adults can legally smoke a joint in Germany under the proposed law. Until then, cannabis will remain prohibited.” A final reading and vote on the cannabis legislation was initially supposed to be held last week but was delayed so it could be discussed next month, according to Germany politician Carmen Wegge. “The CannG will be decided in December,” Wegge wrote on social media. “This means that we are not keeping to the schedule. I know this is a huge disappointment for many. That’s why this decision wasn’t easy for anyone. However, well-designed improvements are in all of our interests.” Kappert-Gonther also expressed the necessity of more time, with promises of improvement. “The #CannaG comes, just a little later. I am confident that the law will become significantly better as a result of the discussions. Some wording still needs to be worked on on some points. This is for a good cause, quality comes before time pressure. Completion scheduled for December,” Kappert-Gonther wrote online. Hopefully progress will continue on track through December with the German Bundestag, which is said to follow discussion within the German Bundesrat.

FAQ: How to use this hemp news hub

What topics does Chow420’s hemp news cover?

We aggregate and surface reputable coverage on hemp laws and enforcement, THC thresholds and policy proposals, cannabinoid products (CBD/Delta-8/hemp-derived THC), compliance, lab testing, recalls, and broader industry news.

Is this legal advice?

No. This page is for news and education. Hemp rules can change quickly and vary by state—always verify against the latest official guidance and consult qualified counsel for compliance decisions.

How do I evaluate hemp product safety claims?

Look for current third‑party COAs (Certificates of Analysis), clear ingredient labeling, and transparent sourcing. Be cautious with vague potency claims or missing lab reports.

Why do some articles mention Delta‑8 or “hemp-derived THC”?

These products often sit at the center of policy and enforcement changes. We track major updates so shoppers and brands can understand evolving requirements and market impacts.

How often is the news updated?

The crawler is scheduled to run daily. New items appear as sources publish updates.